S100B and ischemic stroke: A multicentre study focusing on S100β protein, NSE, GFAP and activated protein C–protein C inhibitor complex demonstrated the ability of GFAP to differentiate haemorrhagic stroke from ischaemic stroke, which has not been observed for other proteins [115].